Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Novartis
Queensland Health
Deloitte
US Department of Justice
Johnson and Johnson
Healthtrust
Julphar
AstraZeneca
McKesson

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202743

« Back to Dashboard
NDA 202743 describes AZELASTINE HYDROCHLORIDE, which is a drug marketed by Sandoz Inc, Upsher-smith Labs, Zydus Pharms Usa Inc, Apotex Inc, Sun Pharma Global, Perrigo Israel, West-ward Pharms Int, Alkem Labs Ltd, Akorn, Amneal Pharms Llc, and Breckenridge Pharm, and is included in sixteen NDAs. It is available from thirteen suppliers. Additional details are available on the AZELASTINE HYDROCHLORIDE profile page.

The generic ingredient in AZELASTINE HYDROCHLORIDE is azelastine hydrochloride; fluticasone propionate. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the azelastine hydrochloride; fluticasone propionate profile page.

Summary for NDA: 202743

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Ophthalmic Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 202743

Suppliers and Packaging for NDA: 202743

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AZELASTINE HYDROCHLORIDE
azelastine hydrochloride
SPRAY, METERED;NASAL 202743 ANDA Perrigo New York Inc 45802-026 45802-026-83 1 BOTTLE in 1 CARTON (45802-026-83) > 200 SPRAY in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY, METERED;NASALStrengthEQ 0.1876MG BASE/SPRAY
Approval Date:May 8, 2014TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Queensland Health
Fish and Richardson
Farmers Insurance
Baxter
Novartis
Deloitte
Cipla
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot